It is impossible to predict the onset of schizophrenic psychosis. If factors linked to a risk of psychosis can be identified, however, these may yield significant insights into its underlying mechanisms. Basel-based scientists have now established a link between particular genes and the size of important brain structures in individuals with an elevated risk of psychosis. The results of the study appear in the latest edition of the scientific journal Translational Psychiatry.
Schizophrenic psychoses are a frequently occurring group of psychiatric disorders caused by a combination of biological, social and environmental factors. These disorders are associated with changes to the brain structure: for example, the hippocampus in the temporal lobe is usually smaller in affected individuals than in healthy ones. It is not yet known whether these changes to the brain structure are a result of the disorders and their accompanying medications, or whether they are already present before the onset of symptoms.
Together with a research group from the University of Basel, Fabienne Harrisberger and Stefan Borgwardt examined the brain structures of individuals exhibiting an elevated risk of psychosis, and those of individuals experiencing the onset of psychotic symptoms for the first time.
Initially, scientists from the Adult Psychiatric Clinic of the University Psychiatric Clinics (UPK) and the Transfaculty Research Platform Molecular and Cognitive Neurosciences (MCN) observed no appreciable difference between the hippocampi of individuals at high risk and those of patients.
Next, together with scientists from the Transfaculty Research Platform, they investigated whether any known schizophrenia risk genes are associated with the hippocampus. This appears to be the case: the greater the number of risk genes a person possessed, the smaller the volume of their hippocampus – regardless of whether they were a high-risk study participant or a patient. This means that a group of risk genes is connected with a reduction in the size of a critical region of the brain before the disorder manifests itself.
Potential for differentiated therapy
This result is significant for the understanding of neurobiological factors contributing to schizophrenia. It is well-known that none of the wider risk factors (e.g. genes, environment, unfavorable social situation) can be used to predict the onset of psychosis in a specific individual. However, the discovery may be of use for the treatment of schizophrenia.
“It is quite possible that individuals with smaller hippocampi will react differently to therapy compared to those with normally developed hippocampi,” explains Prof. Stefan Borgwardt of the Neuropsychiatry and Brain Imaging Unit. Further studies to ascertain the therapeutic potential of this research are planned.
Fabienne Harrisberger, Renata Smieskova, Christian Vogler, Tobias Egli, André Schmidt, Claudia Lenz, Andor E Simon, Anita Riecher-Rössler, Andreas Papassotiropoulos, Stefan Borgwardt
Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis
Translational Psychiatry (2016), doi: 10.1038/TP.2016.143
Prof. Dr. Stefan Borgwardt, University of Basel, Adult Psychiatric Clinic of the University Psychiatric Clinics (UPK), tel. +41 61 325 81 87, email: firstname.lastname@example.org
Prof. Dr. Andreas Papassotiropoulos, University of Basel, Transfaculty Research Platform Molecular and Cognitive Neurosciences, tel. +41 61 267 05 99, email: email@example.com
Olivia Poisson | Universität Basel
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Power and Electrical Engineering
05.12.2016 | Materials Sciences
05.12.2016 | Power and Electrical Engineering